MERCK Kommanditgesellschaft auf Aktien

XETRA MRK.DE

MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin for the year ending December 31, 2023: 55.59%

MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin is 55.59% for the year ending December 31, 2023, a -9.83% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin for the year ending December 31, 2022 was 61.65%, a -1.62% change year over year.
MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin for the year ending December 31, 2021 was 62.66%, a 2.69% change year over year.
MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin for the year ending December 31, 2020 was 61.02%, a -2.86% change year over year.
MERCK Kommanditgesellschaft auf Aktien Gross Profit Margin for the year ending December 31, 2019 was 62.82%, a -1.42% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

XETRA: MRK.DE

MERCK Kommanditgesellschaft auf Aktien

CEO	Ms. Belen Garijo Lopez M.D.
IPO Date	June 26, 1998
Location	Germany
Headquarters	Frankfurter Strasse 250
Employees	62,176
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Key trends

Past 5 years